L26/O-004 Restoring Shugoshin-1 prevents chromosomal errors in ageing human oocytes
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von A. Zielinska und 14 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Is age-related egg aneuploidy an inevitable consequence of reproductive ageing, or can it be prevented through a targeted therapeutic intervention? Summary answer A single pre-fertilisation administration of Shugoshin-1 reduces the incidence of age-related aneuploidy in immature human oocytes by approximately 50%. What is known already Aneuploidy in human oocytes increases sharply with maternal age and is a major cause of infertility, IVF failure and congenital disorders. Age-related aneuploidy predominantly results from premature sister chromatid separation (PSSC), caused by progressive loss of chromosomal cohesion as cohesin complexes decline with advancing maternal age. In adult human eggs, cohesin cannot be replenished due to the absence of a chromatin state permissive for de novo loading. Consequently, no therapeutic strategies currently exist to restore chromosomal cohesion and reduce age-related aneuploidy. Study design, size, duration This multi-centre prospective pre-clinical study involved no modification to patient treatment, as the intervention was performed ex vivo on surplus immature oocytes. Women undergoing ovarian stimulation for egg banking or ICSI were invited to participate. Following informed consent, eggs remaining immature at the time of ICSI were donated for research. The final analysis included 111 human eggs treated at the optimal dose, from more than 30 women aged between 22 and 43 years. Participants/materials, setting, methods Human eggs unsuitable for clinical use were obtained from IVF cycles following informed consent. Immature oocytes (GV or MI stage) were allocated to control or treatment groups, with treated eggs microinjected with Shugoshin-1 mRNA and matured in vitro. Chromosomal integrity was assessed after polar body extrusion to quantify premature sister chromatid separation (PSSC). Age-stratified comparisons were performed between treated and untreated eggs. Main results and the role of chance We identified loss of the cohesin protector Shugoshin 1 as a key contributor to PSSC and, therefore, aneuploidy in aged mammalian eggs. Supplementation with Shugoshin-1 mRNA protected the residual cohesin and decreased the proportion of human eggs exhibiting PSSC by approximately 48% compared with untreated controls. In every paired within-donor comparison, Shugoshin-1 supplementation reduced the percentage of eggs with PSSC, showing a positive therapeutic effect at the level of individual patients. The intervention did not appear to adversely affect in vitro maturation timing or efficacy. Technical replicates and appropriate controls were included to account for experimental variability. Although this approach is still experimental in nature, the observed reduction in chromosomal errors demonstrates a robust effect of Shugoshin-1 restoration. Limitations, reasons for caution This study used immature human eggs, and effect size remains to be established in the faster developing eggs typically used for patient treatment. Therapeutic potential was not assessed in women over 45 years with markedly reduced cohesion. Long-term developmental outcomes were not evaluated. Wider implications of the findings These findings provide the first indication that age-related aneuploidy in human oocytes is preventable and amenable to therapeutic intervention, supported by pre-clinical evidence that restoring Shugoshin-1 levels reduces chromosomal errors and may improve egg quality in advanced maternal age. Trial registration number No
Zitieren
APA
Zielinska, A., Saha, D., Manshaei, S., Jeon, H., Zollo, N., Bondarieva, A., Larreategui, A., Pauer, H., Poorali, V., Blaney, M., Elder, K., Maierova, B., Holubcova, Z., Yagensky, O., & Schuh, M. (2026). L26/O-004 Restoring Shugoshin-1 prevents chromosomal errors in ageing human oocytes. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.004
Vancouver
Zielinska A, Saha D, Manshaei S, Jeon H, Zollo N, Bondarieva A, et al. L26/O-004 Restoring Shugoshin-1 prevents chromosomal errors in ageing human oocytes. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.004
BibTeX
@article{Zielinska2026,
author = {Zielinska, A. and Saha, D. and Manshaei, S. and Jeon, H.J. and Zollo, N. and Bondarieva, A. and Larreategui, A. and Pauer, H.U. and Poorali, V. and Blaney, M. and Elder, K. and Maierova, B. and Holubcova, Z. and Yagensky, O. and Schuh, M.},
title = {L26/O-004 Restoring Shugoshin-1 prevents chromosomal errors in ageing human oocytes},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.004}
}
EUVIMED